Prot #KB105-001: A Phase I/II Study of Topical KB105, a Replication-Incompetent, Non-Integrating HSV-1 Vector Expressing Human Transglutaminase 1 (TGM1) for the Treatment of TGM1-Deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Project: Research project

Project Details

StatusActive
Effective start/end date2/17/202/17/23

Funding

  • Krystal Biotech, Inc. (Prot #KB105-001)